33749643|t|Effects of Folic Acid Combined with DHA Supplementation on Cognitive Function and Amyloid-beta-Related Biomarkers in Older Adults with Mild Cognitive Impairment by a Randomized, Double Blind, Placebo-Controlled Trial.
33749643|a|BACKGROUND: The neuroprotective benefits of combined folic acid and docosahexaenoic acid (DHA) on cognitive function in mild cognitive impairment (MCI) patients are suggested but unconfirmed. OBJECTIVE: To explore the effects of 6-month folic acid + DHA on cognitive function in patients with MCI. METHODS: Our randomized controlled trial (trial number ChiCTR-IOR-16008351) was conducted in Tianjin, China. We divided 160 MCI patients aged > 60 years into four regimen groups randomly: folic acid (0.8 mg/day) + DHA (800 mg/day), folic acid (0.8 mg/day), DHA (800 mg/day), and placebo, for 6 months. Cognitive function and blood amyloid-beta peptide (Abeta) biomarker levels were measured at baseline and 6 months. Cognitive function was also measured at 12 months. RESULTS: A total of 138 patients completed this trial. Folic acid improved the full-scale intelligence quotient (FSIQ), arithmetic, and picture complement scores; DHA improved the FSIQ, information, arithmetic, and digit span scores; folic acid + DHA improved the arithmetic (difference 1.67, 95% CI 1.02 to 2.31) and digital span (1.33, 0.24 to 2.43) scores compared to placebo. At 12 months, all scores declined in the intervention groups. Folic acid and folic acid + DHA increased blood folate (folic acid + DHA: 7.70, 3.81 to 11.59) and S-adenosylmethionine (23.93, 1.86 to 46.00) levels and reduced homocysteine levels (-6.51, -10.57 to -2.45) compared to placebo. DHA lower the Abeta40 levels (-40.57, -79.79 to -1.35) compared to placebo (p < 0.05), and folic acid + DHA reduced the Abeta42 (-95.59, -150.76 to -40.43) and Abeta40 levels (-45.75, -84.67 to -6.84) more than DHA (p < 0.05). CONCLUSION: Folic acid and DHA improve cognitive function and reduce blood Abeta production in MCI patients. Combination therapy may be more beneficial in reducing blood Abeta-related biomarkers.
33749643	11	21	Folic Acid	Chemical	MESH:D005492
33749643	36	39	DHA	Chemical	MESH:D004281
33749643	82	94	Amyloid-beta	Gene	351
33749643	140	160	Cognitive Impairment	Disease	MESH:D003072
33749643	271	281	folic acid	Chemical	MESH:D005492
33749643	286	306	docosahexaenoic acid	Chemical	MESH:D004281
33749643	308	311	DHA	Chemical	MESH:D004281
33749643	343	363	cognitive impairment	Disease	MESH:D003072
33749643	365	368	MCI	Disease	MESH:D060825
33749643	370	378	patients	Species	9606
33749643	455	465	folic acid	Chemical	MESH:D005492
33749643	468	471	DHA	Chemical	MESH:D004281
33749643	497	505	patients	Species	9606
33749643	511	514	MCI	Disease	MESH:D060825
33749643	640	643	MCI	Disease	MESH:D060825
33749643	644	652	patients	Species	9606
33749643	704	714	folic acid	Chemical	MESH:D005492
33749643	730	733	DHA	Chemical	MESH:D004281
33749643	748	758	folic acid	Chemical	MESH:D005492
33749643	773	776	DHA	Chemical	MESH:D004281
33749643	869	874	Abeta	Gene	351
33749643	1008	1016	patients	Species	9606
33749643	1039	1049	Folic acid	Chemical	MESH:D005492
33749643	1147	1150	DHA	Chemical	MESH:D004281
33749643	1218	1228	folic acid	Chemical	MESH:D005492
33749643	1231	1234	DHA	Chemical	MESH:D004281
33749643	1426	1436	Folic acid	Chemical	MESH:D005492
33749643	1441	1451	folic acid	Chemical	MESH:D005492
33749643	1454	1457	DHA	Chemical	MESH:D004281
33749643	1474	1480	folate	Chemical	MESH:D005492
33749643	1482	1492	folic acid	Chemical	MESH:D005492
33749643	1495	1498	DHA	Chemical	MESH:D004281
33749643	1525	1545	S-adenosylmethionine	Chemical	MESH:D012436
33749643	1588	1600	homocysteine	Chemical	MESH:D006710
33749643	1654	1657	DHA	Chemical	MESH:D004281
33749643	1745	1755	folic acid	Chemical	MESH:D005492
33749643	1758	1761	DHA	Chemical	MESH:D004281
33749643	1774	1781	Abeta42	Gene	351
33749643	1865	1868	DHA	Chemical	MESH:D004281
33749643	1893	1903	Folic acid	Chemical	MESH:D005492
33749643	1908	1911	DHA	Chemical	MESH:D004281
33749643	1956	1961	Abeta	Gene	351
33749643	1976	1979	MCI	Disease	MESH:D060825
33749643	1980	1988	patients	Species	9606
33749643	2051	2056	Abeta	Gene	351
33749643	Negative_Correlation	MESH:D004281	MESH:D006710
33749643	Positive_Correlation	MESH:D005492	351
33749643	Cotreatment	MESH:D004281	MESH:D005492
33749643	Positive_Correlation	MESH:D005492	MESH:D006710
33749643	Negative_Correlation	MESH:D004281	351
33749643	Positive_Correlation	MESH:D005492	MESH:D012436
33749643	Positive_Correlation	MESH:D005492	MESH:D003072
33749643	Negative_Correlation	MESH:D004281	MESH:D003072
33749643	Positive_Correlation	MESH:D004281	MESH:D012436
33749643	Negative_Correlation	MESH:D004281	MESH:D060825
33749643	Positive_Correlation	MESH:D005492	MESH:D060825

